Scientific Publications

Tumor immune profiling-based neoadjuvant immunotherapy for locally advanced melanoma

Given that the frequency of “exhausted” or checkpoint-positive (PD-1+CTLA-4+) cytotoxic lymphocytes (Tex) in the tumor microenvironment is correlated with response to anti-PD-1 therapy in metastatic melanoma, researchers ascertained if pretreatment Tex cells in locally advanced melanoma anticipated response to neoadjuvant anti-PD-1 blockade.

Read More

Clinical, environmental, and histological distribution of BRAF, NRAS and TERT promoter mutations among cutaneous melanoma patients. A retrospective study of 563 patients

Given that distinct somatic mutations that define clinical and histopathological heterogeneity in cutaneous melanoma may depend on host susceptibility to exogenous factors such as ultraviolet radiation, researchers conducted a retrospective study on 563 patients with melanoma by examining somatic mutations in BRAF, NRAS and TERT promoter.

Read More
MRV News
Melanoma News
Archive
Menu